Retatrutide is a novel compound exhibiting substantial efficacy in weight control . This drug acts as a twin activator for both receptor and GIP pathways , contributing to enhanced glucose control and lower body fat . Initial patient findings indicate noteworthy weight decrease and positive physiological effects in patients with obesity and related